About Intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome
Intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome is a rare disease catalogued by Orphanet (ORPHA:508512). It is associated with the RMI2, TOP3A genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome trials.
Search ClinicalTrials.gov for "Intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome" or filter by Orphanet code ORPHA:508512 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome. Updated daily.